JGC
NEOS

J. Goldman & Co’s Neos Therapeutics, Inc NEOS Stock Holding History

J. Goldman & Co’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-120,000
Closed -$313K – 430
2019
Q1 		$313K Sell
120,000
-546,000
-82% -$1.28M 0.03% 248
2018
Q4 		$1.1M Sell
666,000
-995,420
-60% -$2.79M 0.14% 176
2018
Q3 		$8.06M Sell
1,661,420
-56,563
-3% -$321K 0.93% 55
2018
Q2 		$10.7M Buy
1,717,983
+478,983
+39% +$3.57M 0.96% 52
2018
Q1 		$10.3M Buy
1,239,000
+589,000
+91% +$5.62M 0.88% 57
2017
Q4 		$6.63M Buy
650,000
+14,135
+2% +$136K 0.62% 85
2017
Q3 		$5.82M Sell
635,865
-209,135
-25% -$1.59M 0.55% 96
2017
Q2 		$6.17M Buy
+845,000
New +$6.38M 0.64% 88

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return